BiotechTube
Sapient Bioanalytics

Sapient Bioanalytics

San Francisco, United States· Est.
sapient.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sapient Bioanalytics is a San Francisco-based biotech services company founded in 2020, specializing in AI-driven multi-omics analysis. The company offers a suite of services spanning discovery proteomics, metabolomics, and lipidomics, supported by its proprietary DynamiQ datasets and a large-scale human sample database. Its core value proposition is to help pharmaceutical and biotech clients identify novel drug targets, validate dynamic biomarkers, and de-risk clinical development through deep data analysis and a pipeline that includes a CLIA-certified, CAP-accredited laboratory.

AI / Machine LearningProteomics

Technology Platform

Integrated multi-omics platform combining high-throughput mass spectrometry-based assays (proteomics, metabolomics, lipidomics) with AI/ML-driven bioinformatics and a proprietary DynamiQ™ dataset derived from >67,000 human samples.

Opportunities

The growing demand for precision medicine and dynamic biomarkers creates a large market for multi-omics services.
The ability to unlock insights from archival FFPE tissues addresses a major unmet need in oncology R&D.
The shift towards AI-driven drug development enhances the value of its proprietary, large-scale human multi-omics database.

Risk Factors

Intense competition from large CROs and specialized omics companies.
Revenue dependency on the R&D spending cycles of biopharma clients.
Technological risk from rapid advancements in competing profiling technologies.

Competitive Landscape

Sapient operates in a crowded market competing with large, full-service CROs (e.g., LabCorp, IQVIA), specialized proteomics companies (e.g., Olink, SomaLogic), metabolomics firms (e.g., Metabolon), and diagnostic service labs. Its differentiation hinges on the depth of its multi-omics coverage, its AI/ML-driven DynamiQ insights, and its unique FFPE proteomics capability.

More companies in Proteomics & Protein Engineering →More companies in United States →